New screening tool aims to spot suicide risk in kids with autism

NCT ID NCT04317118

Completed Knowledge-focused Sponsor: National Institute of Mental Health (NIMH) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a set of questions to better identify suicide risk in young people aged 8–17 with autism or other neurodevelopmental disorders. Researchers asked 278 participants and their parents about thoughts of self-harm and understanding of death. The goal was to create a reliable screening tool for clinics, since no standard method currently exists for this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder Death neurodevelopmental disorder Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDAL IDEATION

Contacts and locations

Locations

Kennedy Krieger Institute/Johns Hopkins University

Baltimore, Maryland, 21205, United States
National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States
Nationwide Children's Hospital/ Ohio State University

Columbus, Ohio, 43201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.